Bapineuzumab could be a blockbuster if it passes final trials
(Newser) -
A drug currently in experimental trials seems to be effective in battling Alzheimer's disease, the pharmaceutical companies developing it tell the
Wall Street Journal. Bapineuzumab—developed by Elan and Wyeth—seems to be helpful in improving cognitive ability in those stricken by the disease, though much more so in patients...
More »
